​

Funding Round

Series A - Reunion Neuroscience

Series A - Reunion Neuroscience

Investment Firm

Overview

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

Announced Date

May 02, 2024

Funding Type

Series A

Highlights

Location

North America

Social

Investor Lead

Novo Holdings

Novo Holdings

Novo Holdings is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

6

Investor Name
Participant InvestorPlaisance Capital Management
Participant InvestorFemHealth Ventures
Participant InvestorMPM Capital
Participant InvestorNovo Holdings
Participant InvestorMitsui Global Investment

Round Details and Background

Reunion Neuroscience raised $103000000 on 2024-05-02 in Series A

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 02, 2024
Series A - Reunion Neuroscience
7-103.0M

Recent Activity

There is no recent news or activity for this profile.